ClinicalTrials.gg
CompletedNCT03354234ORTHO-LBNPUpdated Mar 9, 2026

Evaluation of the ORTHO-LBNP System

An interventional study of Head up tilt (HUT) and Lower body negative pressure (LBNP) in Orthostatic Hypotension, Ischemia and Hypoxia, sponsored by Military Institute of Aviation Medicine. Completed at 1 site in Poland. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-09.

Sponsored by Military Institute of Aviation Medicine · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Jan 2017, registered Nov 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Non-randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

The pilot study aims to evaluate a prototype system that enables military pilots to train under conditions of orthostatic hypotension and ischemic hypoxia. Both of these phenomena are experienced by aircraft crews of mainly highly maneuverable aircraft, and their syndromes include loss of color vision, loss of peripheral vision, blackout and finally G-induced loss of consciousness (G-LOC). A motorized tilt table to generate orthostatic (ORTHO) stress combined with an automatically controlled lower body negative pressure (LBNP) chamber to extort pooling of blood in the lower extremities has been developed in order to obtain new knowledge on counteracting the above-mentioned effects and minimizing the risk of their occurrence. This will help optimize the selection procedures of candidates with the best physiological predispositions to work as military pilots. The system is equipped with modules for monitoring biomedical parameters of a subject, including cerebral oxygenation, which ensures their safety and provides a source of data for performing advanced analyses. The ORTHO-LBNP system has been subjected to comprehensive laboratory tests and after a successful testing is ready for a pilot study involving pilots and/or cadets of the Polish Air Force Academy (PAFA). It is anticipated that new indicators will be proposed to enable an objective assessment of the predispositions to pursue a military pilot career. The prototype system can be easily adaptable to the needs of clinical and sports medicine as well as rehabilitation.

Read the detailed description

The pilot study consists of two research scenarios, in which two different sequences of the interventions taking the form of the pre-programmed tilt and LBNP profiles are to be investigated.

  1. Scenario I is designed to initially verify the potential impact of the prototype system on the human body. For this purpose, only basic tilt and LBNP stimuli of relatively slowly increasing intensities will be used, and the group of subjects will include only subjects with flight experience. Up to 20 PAFA cadets shortly before graduation, including women and men, will be involved in the pilot study (experimental arm 1). The subjects will be healthy, aged between 20 and 30 years old. Scenario I will take almost 24 min.
  2. Scenario II is to compare subjects with and without flight experience using rapid tilt and LBNP stimuli as well as a push-pull stimulus. Up to 30 subjects including up to 15 pilots, i.e., flight school adepts shortly after graduation and/or PAFA cadets shortly before graduation, and up to 15 students of the Aviation High School in Dęblin, Poland, including women and men will be involved in the study (experimental arm 2). The subjects will be healthy, aged between 18 and 30 years old. The students of the Aviation High School will participate in the study as a reference group, without flight experience. Scenario II will take 16 min.

The pilot study will be carried out in an isolated room in the presence of a physician (physiologist), a paramedic and an ORTHO-LBNP system operator. The paramedic will prepare the subject for the study by placing on his/her body electrodes and measuring sensors that will be removed after completion of the study. The subject will be asked to close his/her eyes during the tests and to place his/her hands on the rest. In order to cause the least disturbance, no conversation will be held with the subject. Only if disturbing symptoms will occur, will the subject immediately report this to the personnel. The physician will systematically be observing the subject's cardiogram, his/her HR, continuous non-invasive arterial pressure (CNAP) wave, and systolic and diastolic blood pressure (SBP and DBP, respectively) in comparison with the changing tilt of the table and negative pressure in the chamber. Any time, at the request of the subject or on the instruction of the physician, the operator will interrupt the tests. The tilt table then will return to the Trendelenburg position if interruption occur during HUT and/or LBNP stimuli, or horizontal position if interruption occur during HDT stimulus. At the same time atmospheric pressure will be resumed in the chamber.

02

Conditions studied

  • Orthostatic Hypotension
  • Ischemia
  • Hypoxia

Keywords

  • Gz accelerations
  • Head up tilt (HUT) test
  • Lower body negative pressure (LBNP) method
  • Physiological parameters
  • Variable gravitational stimuli
03

In context

Hypotension, Orthostatic

159 studies on the registry are indexed under Hypotension, Orthostatic; 35 are open to participants now.

This study's enrollment of 46 is above the median of 28 across 113 interventional studies indexed under Hypotension, Orthostatic.

Browse Hypotension, Orthostatic studies →

Lead sponsor

Military Institute of Aviation Medicine is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pilots or cadets with flight experience
  • Candidates for pilots without flight experience
  • None alcohol 24 hours prior to the study
  • Written

Exclusion criteria

Exclusion Criteria:

  • Subjects with cardiovascular disorders
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
46 participants (actual)

Study arms

  • Experimental
    Stimuli of slowly increasing intensities

    1. 300-s check before the stimuli 2. LBNP is applied stepwise with 11.1 mmHg/15 s decrement to -100 mmHg, and then this value is sustained for 120 s 3. 180-second phase of rest between stimuli 4. 75°-HUT (5°/s) for 120 s after a 15-s reversing of the gravity vector (-30°) 5. 180-second phase of rest between stimuli 6. 75°-HUT (5°/s) accompanied by an exposure to an LBNP of -60 mmHg increased linearly by -4 mmHg/s, and then this value is sustained for 120 s during HUT 7. 120-s check after the stimuli

    Other: Head up tilt (HUT) · Other: Lower body negative pressure (LBNP) · Other: Head down tilt (HDT) · Device: Tilt table · Device: LBNP chamber

  • Experimental
    Stimuli of rapidly increasing intensities

    1. 120-s check before the stimuli 2. 75°-HUT (45°/s) for 60 s after a 3-s reversing of the gravity vector (-30°) 3. 180-second phase of rest between stimuli 4. LBNP decreases linearly by -20 mmHg/s to -100 mmHg, and then this value is sustained for 60 s. 5. 180 second phase of rest between stimuli 6. push-pull, i.e., 3 x 75°-HUT (45°/s) preceded by -30°-HDT (45°/s) and accompanied by an exposure to an LBNP of -60 mmHg decreased linearly by -20 mmHg/s, and then this value is sustained for 30 s during HUT 7. 120-s check after the stimuli

    Other: Head up tilt (HUT) · Other: Lower body negative pressure (LBNP) · Other: Head down tilt (HDT) · Device: Tilt table · Device: LBNP chamber

Interventions

  • OtherHead up tilt (HUT)

    Model of -Gz: HUT up to 75 degrees (maximum)

  • OtherLower body negative pressure (LBNP)

    Model of -Gz: LBNP down to -100 mmHg (maximum)

  • OtherHead down tilt (HDT)

    Model of +Gz: HDT down to -30 degrees (maximum)

  • DeviceTilt table

    Range of tilt angles: -45° to +80°, rate of tilt changes: up to 45°/s

  • DeviceLBNP chamber

    Range of generated underpressure: 0 to -100 mmHg, rate of underpressure changes: up to 20 mmHg/s

06

What researchers measure

Primary outcomes

  1. HR

    Heart rate in beats per minute

    Time frame: 24 minutes (scenario I)

  2. IBI

    Inter-beat interval in seconds

    Time frame: 24 minutes (scenario I)

  3. SBP

    Systolic blood pressure in millimeters of mercury

    Time frame: 24 minutes (scenario I)

  4. DBP

    Diastolic blood pressure in millimeters of mercury

    Time frame: 24 minutes (scenario I)

  5. MAP

    Mean arterial pressure in millimeters of mercury

    Time frame: 24 minutes (scenario I)

  6. SV

    Stroke volume in milliliters

    Time frame: 24 minutes (scenario I)

  7. CO

    Cardiac output in liters per minute

    Time frame: 24 minutes (scenario I)

  8. LVET

    Left ventricular ejection time in milliseconds

    Time frame: 24 minutes (scenario I)

  9. RPP

    Rate pressure product in millimeters of mercury

    Time frame: 24 minutes (scenario I)

  10. TPR

    Total peripheral resistance in medical units

    Time frame: 24 minutes (scenario I)

Secondary outcomes

  1. Z0_T

    Base transthoracic impedance in ohms

    Time frame: 16 minutes (scenario II)

  2. dZ/dt_T

    First derivative of transthoracic impedance in ohms per second

    Time frame: 16 minutes (scenario II)

  3. Z0_H

    Base transcephalic impedance in ohms

    Time frame: 16 minutes (scenario II)

  4. dZ/dt_H

    First derivative of transcephalic impedance in ohms per second

    Time frame: 16 minutes (scenario II)

  5. ΔC_HbO2

    Changes in oxygenated hemoglobin in micromolars

    Time frame: 16 minutes (scenario II)

  6. ΔC_Hb

    Changes in deoxygenated hemoglobin in micromolars

    Time frame: 16 minutes (scenario II)

  7. ΔC_tot

    Changes in total hemoglobin in micromolars

    Time frame: 16 minutes (scenario II)

07

Study locations

1 site
  • Military Institute of Aviation Medicine
    Warsaw, 01-755, Poland
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2017 to primary completion in Feb 2018, 13 months.

Of 34 interventional studies with no phase under Hypotension, Orthostatic, half reached primary completion within 54 months of starting (the median), counting those still running; a quarter within 32 and three quarters within 70. This study's 13 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 10, 2017
First posted
Nov 27, 2017
StartActual
Jan 2, 2017
Primary completionActual
Feb 17, 2018
CompletionActual
Feb 17, 2018
Last update
Mar 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03354234
Lead sponsor
Military Institute of Aviation Medicine
Collaborators
Institute of Medical Technology and Equipment, Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Polish Air Force Academy, ETC-PZL Aerospace Industries Sp. z o.o.
Responsible party
Sponsor
First posted
Nov 27, 2017
Start date
Jan 2, 2017
Primary completion
Feb 17, 2018
Completion
Feb 17, 2018
Last update
Mar 9, 2026

Study contacts

Łukasz Dziuda, DSc, PhD
principal investigator · Military Institute of Aviation Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion